BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 248 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27 | +3.8% | 531 | +27.6% | 0.00% | – |
| Q2 2023 | $26 | +36.8% | 416 | -2.3% | 0.00% | – |
| Q1 2023 | $19 | -24.0% | 426 | -26.4% | 0.00% | – |
| Q4 2022 | $25 | -99.9% | 579 | +58.6% | 0.00% | – |
| Q3 2022 | $24,000 | +50.0% | 365 | +13.0% | 0.00% | – |
| Q2 2022 | $16,000 | -23.8% | 323 | -3.3% | 0.00% | – |
| Q1 2022 | $21,000 | -38.2% | 334 | +4.4% | 0.00% | – |
| Q4 2021 | $34,000 | +21.4% | 320 | +1.3% | 0.00% | – |
| Q2 2021 | $28,000 | 0.0% | 316 | 0.0% | 0.00% | – |
| Q1 2021 | $28,000 | 0.0% | 316 | 0.0% | 0.00% | – |
| Q4 2020 | $28,000 | 0.0% | 316 | 0.0% | 0.00% | – |
| Q3 2020 | $28,000 | 0.0% | 316 | 0.0% | 0.00% | – |
| Q2 2020 | $28,000 | 0.0% | 316 | 0.0% | 0.00% | – |
| Q1 2020 | $28,000 | 0.0% | 316 | 0.0% | 0.00% | – |
| Q4 2019 | $28,000 | 0.0% | 316 | 0.0% | 0.00% | – |
| Q3 2019 | $28,000 | 0.0% | 316 | 0.0% | 0.00% | – |
| Q2 2019 | $28,000 | 0.0% | 316 | 0.0% | 0.00% | – |
| Q1 2019 | $28,000 | – | 316 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 878,875 | $70,354,000 | 45.87% |
| CVI Holdings, LLC | 200,000 | $16,010,000 | 15.16% |
| Foresite Capital Management III, LLC | 467,682 | $37,438,000 | 9.74% |
| Casdin Capital, LLC | 848,648 | $67,934,000 | 7.46% |
| BVF INC/IL | 564,965 | $45,225,000 | 5.06% |
| Ghost Tree Capital, LLC | 240,000 | $19,212,000 | 5.02% |
| DAFNA Capital Management LLC | 119,718 | $9,583,000 | 4.13% |
| HHLR ADVISORS, LTD. | 1,498,516 | $119,956,000 | 3.34% |
| Opaleye Management Inc. | 130,000 | $10,407,000 | 2.88% |
| Perceptive Advisors | 1,271,054 | $101,748,000 | 2.87% |